American Academy of Dermatology--Summer Meeting. 29 July-2 August 2009, Boston, MA, USA.
The 2009 Summer Meeting of the American Academy of Dermatology held in Boston, MA included topics covering new therapeutic developments in the field of dermatology. This conference report highlights selected presentations on the use of TNF agents and treatment options for psoriasis and psoriatic arthritis, as well as for melanoma and basal cell carcinoma. Investigational drugs discussed include PLX-4032 (Plexxikon Inc/F Hoffmann-La Roche Ltd) and GDC-0449 (Curis Inc/Genentech Inc/ F Hoffmann-La Roche Ltd).
Whang
Talley
T
Mount Sinai School of Medicine, 5 East 98th Street, New York, NY 10029, USA. talley.whang@mountsinai.org
Goldenberg
Gary
G
D000047:Academies and Institutes / Q000639:trends; D000287:Administration, Topical; D000818:Animals; D001900:Boston; D003879:Dermatologic Agents / Q000008:administration & dosage; D003880:Dermatology / Q000639:trends; D006801:Humans; D012621:Seasons; D012955:Societies, Medical / Q000639:trends; D014481:United States
D003879:Dermatologic Agents